Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-04

Clinical Trial Update: Topical Ruxolitinib Lichen Planus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial for topical ruxolitinib in lichen planus has completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Aaron R. Mangold | Conditions: Lichen Planus | Phase 2 | Status: COMPLETED | Results posted: 2021-08-04